DNMT1 and cancer: In addition to the phytotherapy, emerging epigenetic therapeutics, including mRNA regulators (such as miRNA mimics and antagomiRs), DNA methyltransferase (DNMT) inhibitors, and histone-modifying enzymes, have shown promise in reversing these aberrant alterations, positioning them as potential candidates for cancer therapy [53].